Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström
Nanoform Finland Plc | Company Release | March 02, 2026…
Nanoform Finland Plc – Manager’s Transactions – Antonio Da Silva
Nanoform Finland Plc | Company Release | March 02, 2026…
Nanoform Finland Plc – Manager’s Transactions – Peter Hänninen
Nanoform Finland Plc | Company Release | March 02, 2026…
Nanoform Finland Plc – Manager’s Transactions – David Rowe
Nanoform Finland Plc | Company Release | March 02, 2026…
Nanoform Finland Plc – Manager’s Transactions – Edward Hæggström
Nanoform Finland Plc | Company Release | March 02, 2026…
Nanoform Finland Plc – Manager’s Transactions – Christian Jones
Nanoform Finland Plc | Company Release | March 02, 2026…
The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees
Nanoform Finland Plc | Company Release | March 02, 2026…
Nanoform Q4 & FY2025 report – Next: the submission of a marketing authorization application for Nanoenzalutamide in Europe
Nanoform Finland Plc | Company Release | February 26, 2026…
Invitation to Nanoform’s Q4 and FY2025 Report Presentation
Nanoform Finland Plc | Press Release | February 13, 2026…
Nanoform – Subcutaneously administered Nanotrastuzumab matches performance of Herceptin HYLECTA in minipig study
Nanoform Finland Plc | Press Release | February 12, 2026…
Nanoform Finland Plc’s change negotiations have ended
Nanoform Finland Plc | Company Release | February 05, 2026…
Nanoform – Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act
Nanoform Finland Plc | Company Release | January 29, 2026…
Inside information: Nanoform starts change negotiations as part of announced new midterm business targets for 2030
Nanoform Finland Plc | Inside Information | January 07, 2026…